Cartesian Therapeutics
RNAC
RNAC
87 hedge funds and large institutions have $57.2M invested in Cartesian Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $63.2M → $57.2M (-$6.04M)
24% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 29
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Holders
87
Holding in Top 10
1
Calls
$90K
Puts
$3K
Top Buyers
| 1 | +$4.25M | |
| 2 | +$1.27M | |
| 3 | +$308K | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$212K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$90.8K |
Top Sellers
| 1 | -$3.68M | |
| 2 | -$1.38M | |
| 3 | -$1.36M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$579K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$404K |